X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform

Content Team by Content Team
13th February 2024
in Health & Nutrition, News
Danone Ltd invests €100m in specialized nutrition in China

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Hologram Sciences, a leader in health technology and personalized nutrition, is collaborating with Mayo Clinic for the development of the ‘Precision Nutrition Platform’. This initiative employs advanced machine learning and adaptive technologies, drawing on the clinical insights of Mayo Clinic through a know-how agreement with the goal of addressing the widespread challenges of malnutrition in surgical recovery and enhancing patient care across multiple disciplines.

A key feature of the platform will be its predictive analytics capability, which can identify potential health risks based on dietary patterns and suggest preventive measures directly to patients. These proactive interventions have the potential to be instrumental in optimizing patient outcomes and supporting lasting habit change, marking a shift from reactive to proactive patient care.

Malnutrition poses a significant challenge in hospital environments, affecting patient recovery, outcomes, and readmission rates. Approximately 42% of hospitalized adult patients are malnourished.1 Malnourished hospitalized patients are 56% more likely to be readmitted2 and cost twice as much to treat versus their well-nourished counterparts.3 The Precision Nutrition Platform addresses malnutrition holistically, consistent with emerging gold-standard protocols like Enhanced Recovery after Surgery (ERAS), which puts significant emphasis on nutrition.

Hologram Sciences will develop a new Precision Nutrition Platform for application in clinical settings, integrating Mayo Clinic’s protocols and expertise. The overall platform will leverage Hologram’s personalized nutrition infrastructure, which has been evolving since 2015 to optimize for patient engagement and habit change.

Manpreet S. Mundi, M.D., Medical Director of Clinical Nutrition and an expert in bariatric care at Mayo Clinic, and his team will provide insights to the development process to ready this system for clinical practice.

Clinical Impact of the AI-Enabled Precision Nutrition Platform

The platform intends to provide a dual-interface system, tailored for both patient interaction and physician monitoring. Patients can engage with the platform for customized coaching and feedback, directly impacting their nutritional journey and recovery process. Concurrently, physicians can access a separate interface with the goal of enabling them to closely monitor their patients’ adherence to clinical protocols. The system will alert physicians and clinical staff if direct intervention is needed.

An additional aim of the platform is to enable scalable interactions between Registered Dietitians and patients, which would allow more patients to benefit from their specialized expertise. Combining this personal interaction with a robust nutritional database and a UI that has been fine-tuned to support habit change gives the Precision Nutrition Platform the potential to be a powerful tool in the hands of both patients and healthcare professionals.

First Stress Case: Bariatric Procedures

Initially focusing on bariatric and gastrointestinal surgeries where nutrient absorption is critical, the platform will seek to support patients through pre-surgery preparation and a two-year post-surgery recovery process, offering personalized dietary plans, guidance, and monitoring.

Additional features will include an interactive interface to foster community engagement and provide on-demand access to Registered Dietitians. This human touch seeks to complement the protocol-driven guidance, ensuring a well-rounded patient support system.

Ian Brady, CEO of Hologram Sciences, speaks on the initiative: “Our collaboration with Mayo Clinic is a significant stride in leveraging our technology to personalize patient care. The Precision Nutrition Platform’s goal is to build on our extensive technical capabilities and human insights collected over eight years to meet the intricate nutritional requirements of patients undergoing surgical procedures, ensuring a more successful recovery and long-term wellness.

Previous Post

Lab Automation & Digital Shift To Enhance SDG 2030 Agenda

Next Post

Analytical Laboratory Instruments Eying Record High By 2028

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

Analytical Laboratory Instruments Eying Record High By 2028

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In